Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries
Claes-Göran Ostenson, Stephan Matthaei, Matthew Reaney, Thure Krarup, Bruno Guerci, Jacek Kiljanski, Carole Salaun-Martin, Hélène Sapin, David Bruhn, Chantal Mathieu, Michael Theodorakis
Dyk ned i forskningsemnerne om 'Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries'. Sammen danner de et unikt fingeraftryk.